What is Globus Medical's market cap?

Globus Medical (GMED) has a market capitalization of $10.6B and trades on NYSE.

What is Globus Medical's revenue and profitability?

Globus Medical generated $3.1B in trailing twelve-month revenue with net income of $586.7M, representing a net margin of 18.9%. Gross margin stands at 67.9%, with free cash flow of $610.3M. These figures are based on the Q1 2026 filing.

Who are Globus Medical's competitors?

Globus Medical's key competitors include Orthofix, Stryker, Alphatec Holdings, and others. These companies compete in similar markets and product categories.

What subsidiaries does Globus Medical have?

Globus Medical's subsidiaries include NuVasive, Inc., Nevro Corp., Synoste Oy, and others.

Where is Globus Medical headquartered?

Globus Medical is headquartered in United States of America and employs approximately 5,000 people. It has been publicly traded since 2012.

Globus Medical

GMED

Globus Medical is a leading medical device company focused on developing and commercializing healthcare solutions for patients with musculoskeletal disorders.

Market cap

$10.62B+46.8%

Revenue$3.1B+23.5%

Net income$586.7M+216%

Free cash flow$610.3M+16.8%

EPS (diluted)$4.29+220%

Trailing twelve months · change vs. prior year

Table of contents

Earnings

Q1 2026 report

May 7, 2026

Revenue$759.9MBeat by $19.5M EPS$1.12Beat by $0.20

Read the full report

Next report

Aug 6, 2026 (In 1 week)

Revenue estimate$782.9M

EPS estimate$1.12

Financials

Q1 2026

Income statement

See full

Revenue$759.9M+27.0%

Gross profit$525.8M+30.6%

Operating income$150.4M+55.0%

Net income$124.3M+64.7%

EPS (diluted)$0.90+66.7%

Balance sheet

See full

Cash & equivalents$561.0M+21.6%

Total debt$116.3M+25.0%

Total equity$4.7B+15.8%

Total assets$5.4B+15.5%

Cash flow

See full

Operating cash flow$202.4M+14.1%

CapEx$39.6M+9.7%

Free cash flow$162.7M+15.3%

Valuation & ratios

Valuation

See full

Market cap$10.62B+46.8%

Enterprise value$10.18B+40.5%

P/E18.1×-2.5×

P/S3.4×+0.6×

Profitability

See full

Gross margin67.9%+7.3pp

Operating margin17.2%+7.0pp

Net margin18.9%+11.5pp

FCF margin19.7%-1.1pp

Returns & leverage

See full

Return on equity13.3%+8.7pp

Debt / equity0×0.0×

Current ratio4.6×+0.1×

Segments

By product

See full

Musculoskeletal Solutions$733.0M—

Enabling Technologies$26.9M—

By segment

See full

Reportable Segment$759.9M+27.0%

Competitors

By market cap

Stryker$129.09B-15.7%

Medtronic$107.81B-8.5%

Boston Scientific$67.6B-56.8%

Zimmer Biomet Holdings$17.8B-6.2%

Globus Medical$10.6B+44.5%

IAR

Integra LifeSciences$1.5B+49.2%

Alphatec Holdings$1.3B-18.5%

Orthofix Medical Inc.$481.0M+7.7%

By revenue growth

Globus Medical+23.5%

Alphatec Holdings+22.6%

Boston Scientific+13.5%

Zimmer Biomet Holdings+9.2%

Stryker+8.8%

Medtronic+8.4%

Orthofix Medical Inc.+2.6%

IAR

Integra LifeSciences+1.6%

By net margin

Globus Medical18.92%+11.5pp

Boston Scientific17.48%+4.0pp

Stryker13.21%+0.9pp

Medtronic13.2%-0.7pp

Zimmer Biomet Holdings9.05%-2.8pp

IAR

Integra LifeSciences-0.44%+32.4pp

Orthofix Medical Inc.-7.27%+10.5pp

Alphatec Holdings-15.93%+9.8pp

Profile

Globus Medical is a leading medical device company focused on developing and commercializing healthcare solutions for patients with musculoskeletal disorders. The company leverages an engineering-driven product development engine to provide a comprehensive portfolio of spinal implants, orthopedic trauma solutions, and robotic surgical platforms. Its core value proposition centers on improving clinical outcomes and surgical efficiency through the integration of advanced hardware and enabling technologies.

Competitive position

Globus Medical is a major player in the spine and orthopedic markets, distinguished by its rapid product development cycle and the integration of robotic navigation with traditional implants.

GeographiesUnited States, Global

Customer segmentsHospitals, Ambulatory Surgery Centers, Specialized Physicians

Business modelDirect Sales, Manufacturing, Service-as-a-Product

SuppliersThird-party precision manufacturers, Tissue banks for allograft supply, Specialized component suppliers for robotics, Raw material providers for implants

CustomersHospitals, Ambulatory Surgery Centers, Surgical Clinics, Healthcare Purchasing Organizations

CountryUnited States of America

Listed2012

Employees5.0K

CEOKeith W. Pfeil

SectorHealthcare

IndustryMedical - Devices

Websiteglobusmedical.com

FilingsSEC EDGAR

Ask your AI about Globus Medical.

Connect your AI assistant and dig into the numbers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is Globus Medical's market cap?: Globus Medical (GMED) has a market capitalization of $10.6B and trades on NYSE.
What is Globus Medical's revenue and profitability?: Globus Medical generated $3.1B in trailing twelve-month revenue with net income of $586.7M, representing a net margin of 18.9%. Gross margin stands at 67.9%, with free cash flow of $610.3M. These figures are based on the Q1 2026 filing.
Who are Globus Medical's competitors?: Globus Medical's key competitors include Orthofix, Stryker, Alphatec Holdings, and others. These companies compete in similar markets and product categories.
What subsidiaries does Globus Medical have?: Globus Medical's subsidiaries include NuVasive, Inc., Nevro Corp., Synoste Oy, and others.
Where is Globus Medical headquartered?: Globus Medical is headquartered in United States of America and employs approximately 5,000 people. It has been publicly traded since 2012.